uMotif Revenue and Competitors

London, UK

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • uMotif's estimated annual revenue is currently $22.9M per year.(i)
  • uMotif's estimated revenue per employee is $270,000

Employee Data

  • uMotif has 85 Employees.(i)
  • uMotif grew their employee count by -19% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$25.1M93-3%N/AN/A
#2
$35.6M1323%N/AN/A
#3
$61.5M2075%N/AN/A
#4
N/A0N/AN/AN/A
#5
$23M85-19%£8.2MN/A
#6
$7.1M33-8%N/AN/A
#7
$17.7M73-4%N/AN/A
#8
$150.5M4469%N/AN/A
#9
$159.3M4725%N/AN/A
#10
$122.9M3646%N/AN/A
Add Company

uMotif is the leading modern data capture platform for research, that patients love to use. With industry leading expertise in Real World and non-interventional studies, the engaging and clinically-proven platform captures e-consent, eCOA / ePRO, symptom and wearable device data. Working with top pharma, CROs and e-clinical platforms, uMotif can be deployed quickly across the world in any condition. uMotif is part of the Journal of mHealth's 2017 Digital Health 100.

keywords:N/A

N/A

Total Funding

85

Number of Employees

$22.9M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

uMotif's People

NameTitleEmail/Phone
1
VP MarketingReveal Email/Phone
2
Director Business DevelopmentReveal Email/Phone
3
Senior Engineer - DevopsReveal Email/Phone
4
Quality Systems ManagerReveal Email/Phone
5
Lead Project ManagerReveal Email/Phone
6
Market Development SpecialistReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Senior iOS DeveloperReveal Email/Phone
9
Chief Technology OfficerReveal Email/Phone
10
Scrum MasterReveal Email/Phone

uMotif News

2020-09-04 - Healthtech startup uMotif lands £5M

AlbionVC has led a £5 million Series A for uMotif, the London-based developer of an app that records and measures patients' health during clinical trials. The capital will go toward its international expansion and the development of new study designs. View details

2020-09-03 - London’s uMotif secures £5 million to decentralise clinical trials and get therapies to patients faster

London-based uMotif, a software that captures patient data for clinical studies, has raised £5 million in a Series A round led by existing investor AlbionVC, with participation from Norwegian firm DNV GL and angel investors. By creating a more engaging experience for study participants, uMotif ...

2020-09-03 - London-based uMotif raises £5m Series A

London-based uMotif – the patient-centric data capture software company has raised £5 million in a Series A investment round led by existing investor AlbionVC. The funding, which also saw participation from Oslo-based DNV-GL and existing angel investors, will accelerate uMotif’s growth and will ...

2019-09-05 - Omni-channel in Healthcare Market 2019 Estimate to Boost ...

Exscientia, Science 37, Transparency Life Sciences, and uMotif IBM Corporation, Accenture PLC, AT&T Inc., CGI Group Inc., Syntel Inc. and ...

2018-06-26 - uMotif gets $3.2M for patient-first approach to clinical trial ...

Patient-facing clinical trial software company uMotif has raised $3.2 million (£2.4 million) in a new funding round led by independent investment ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M855%N/A
#2
$18.7M85-18%N/A
#3
$18.7M85-4%N/A
#4
$7.5M850%N/A
#5
$21.5M8512%N/A